The Optispan Podcast with Matt Kaeberlein cover image

New Discovery: This Molecule Could Beat Rapamycin in Longevity

The Optispan Podcast with Matt Kaeberlein

00:00

Funding realities and commercial paths

They acknowledge tradeoffs between open science and for‑profit funding, plus investor expectations.

Play episode from 39:15
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app